drugset / Trial / NCT00814645

Dose-Finding, Safety, Pharmacodynamic Effect Study of Sodium Nitrite Inhalation Solution in Normal, Healthy Volunteers

NCT00814645

Phase 1 Completed 25 enrolled Aires Pharmaceuticals, Inc.
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This study is designed to investigate the safety and tolerability of AIR001 Inhalation Solution when administered under conditions of hypoxia and to identify dose levels of drug resulting in a reduction in pulmonary arterial pressure under these hypoxic conditions.

Timeline

Start
2008-12
Primary completion
2009-04
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sodium Nitrite Small molecule 5 mg Inhaled
Comparator Sodium Nitrite Small molecule 15 mg Inhaled
Comparator Sodium Nitrite Small molecule 45 mg Inhaled
Comparator Sodium Nitrite Small molecule 113 mg Inhaled